Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Women more at risk for colorectal cancer

A new study of gender and risk factors for colorectal cancer reveals that while both tobacco and alcohol increase risk for colorectal cancer, women who smoke are at higher risk.

1 Nov 2005

Unique approach to enhance the immune system in patients with breast or colorectal cancer

The study uses a potent immune-enhancing gene delivered directly into the cancer cells to make them look foreign to the body's immune system, which will then attack and destroy the cancer.

1 Nov 2005

Colon cancer hits blacks at a younger age

In a review of medical records researchers say that African-Americans are more susceptible to colon cancer at an earlier age than whites.

31 Oct 2005

Preventing bowel cancer in high risk families

Bowel cancer rates could be reduced by up to 80 per cent in people with a moderate family history of the disease by screening with colonoscopy, according to new research published in the British Medical Journal.

26 Oct 2005

Mechanisms of evolution may be associated with disease

By comparing the human genome with that of the chimpanzee, man's closest living relative, researchers have discovered that chunks of similar DNA that have been flipped in orientation and reinserted into chromosomes are hundreds of times more common in primates than previously thought.

26 Oct 2005

Radiation therapy combined with hormone therapy after surgery is more effective in keeping the breast cancer from returning

The current standard of care for early-stage breast cancer is breast conserving surgery (lumpectomy) to remove the tumor followed by radiation and hormone therapy to kill any remaining cells.

17 Oct 2005

Colorectal cancer screening rates remain low

Investigators failed to see improvement in colorectal cancer (CRC) screening rates among patients enrolled in a managed care health plan after testing the effectiveness of a CRC screening promotion program targeting the physician organizations (POs).

10 Oct 2005

CT colonography best choice for regular screening for cancer

Colorectal cancer is the second leading cause of cancer deaths in most developed countries. Screening for colorectal malignancies and polyps (which frequently become cancerous) has been shown to lower the number of deaths from cancer. Most cancer societies and preventive task forces recommend regular screening for cancer of the colon.

10 Oct 2005

Colorectal cancer screening rates are too low

An intervention program designed to promote screening for colorectal cancer – and thereby decrease the number of cancers diagnosed - failed to increase screening rates in the managed care setting, a University of California - Los Angeles study has found.

10 Oct 2005

Gene variation may play fundamental role in the development and spread of cancer in the body

New research shows that a small gene variation that increases the risk of inherited cancer can also arise during the development of spontaneous, or non-inherited, tumors.

9 Oct 2005

Americans' risk of dying from cancer continues to decline

The nation's leading cancer organizations report that Americans' risk of dying from cancer continues to decline and that the rate of new cancers is holding steady. The "Annual Report to the Nation on the Status of Cancer, 1975-2002," published in the Oct. 5, 2005, issue of the Journal of the National Cancer Institute, shows observed cancer death rates from all cancers combined dropped 1.1 percent per year from 1993 to 2002.

4 Oct 2005

Common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer

A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.

4 Oct 2005

Change in gene may be underlying molecular defect in some colorectal cancers

Inactivation of a DNA repair gene may be an early step in the development of sporadic colorectal tumors, and detection of the molecular basis for this inactivation may ultimately be useful in risk assessment for colorectal cancer, according to a new study in the current issue of the Journal of the National Cancer Institute.

22 Sep 2005

Change in gene may be underlying molecular defect in some colorectal cancers

Inactivation of a DNA repair gene may be an early step in the development of sporadic colorectal tumors, and detection of the molecular basis for this inactivation may ultimately be useful in risk assessment for colorectal cancer, according to a new study in the September 21 issue of the Journal of the National Cancer Institute.

20 Sep 2005

Taking aspirin longterm could reduce colorectal cancer risk

According to new report from the Nurses' Health Study (NHS), regular, long-term aspirin use can significantly reduce the risk of colorectal cancer.

24 Aug 2005

Aspirin use can significantly reduce the risk of colorectal cancer

A new report from the Nurse's Health Study finds that regular, long-term aspirin use can significantly reduce the risk of colorectal cancer, as suggested by several earlier studies.

23 Aug 2005

Mutations in the targets of designer drugs critically influence their effectiveness

Two designer cancer drugs differed dramatically in a laboratory test comparing their ability to shut down a mutant, overactive growth signal in lung cancer cells, reports a team headed by scientists at the Dana-Farber Cancer Institute.

18 Aug 2005

Men and women receive remarkably similar outpatient care at the Department of Veterans Affairs (VA),

The study looked at nine measures of quality care that are equally appropriate for women and men, including pneumonia and influenza vaccinations; colorectal cancer screenings; and eye examinations for diabetics, to determine what percentage of VA patients received appropriate care for their gender.

11 Aug 2005

Important breast cancer discovery

Scientists at the McGill University Health Centre (MUHC) have made an important discovery that will advance our understanding of how the female hormone estrogen causes growth of breast cancer cells. The research, in collaboration with scientists at the Institut de Recherches Cliniques de Montreal (IRCM) identifies 153 genes that respond to estrogen and one in particular that can be used to halt the growth of breast cancer cells.

10 Aug 2005

Switching treatment to the drug anastrozole after two years of tamoxifen is beneficial for women with early breast cancer

Switching treatment to the drug anastrozole after two years of tamoxifen can improve eventfree survival for postmenopausal women with early breast cancer, concludes a study in this week’s issue of The Lancet.

4 Aug 2005